DATA-Waiver

Waiver registration is no longer required to treat patients with opioid use disorder.

Obtain or Renew DEA Registration

Save Time, Apply Online

CLICK HERE TO GET STARTED!

DEA FORMS & APPLICATIONS

NEED TO REGISTER, REPORT OR SUBMIT A TIP?

OUR FORMS & APPLICATIONS WILL ASSIST YOU

Year Round Pharmaceutical Disposal

SEARCH FOR YEAR ROUND PHARMACEUTICAL DISPOSAL LOCATIONS

CLICK HERE TO GET STARTED!

INFORMATIONAL DOCUMENTS

PUBLICATIONS & MANUALS

CLICK HERE TO GET STARTED!

Follow @DEA on Twitter

LOOK FOR #DEADIVERSION

CLICK HERE TO GET STARTED!

CONTROLLED SUBSTANCE SCHEDULES

REVIEW THE LIST OF CONTROLLED SUBSTANCES, EXEMPTED LISTS & DEFINITION OF CONTROLLED SUBSTANCE SCHEDULES

CLICK HERE TO GET STARTED!

Registration

Forms &Applications

Hours 8:30am–5:50pm ET

Phone 1-800-882-9539

Email Email Us

DEA Offices Find Local Office

Contact Us

Resources

We are currently experiencing higher than expected CSOS call volume. Your call is very important to us, and we appreciate your patience as we work to assist you as quickly as possible.

Read about upcoming enhancements to CSOS here.

We are resolving an issue with the NFLIS DQS functionality. We anticipate the problem will be resolved soon.

Welcome

Go to Registration

Forms & Applications

Go to Forms

Questions & Answers

Go to Q&A

Meetings & Events

Go to Meetings

Guidance Documents Portal

Go to Portal

Go to Disposal

Controlled Substance Schedules

Go to Schedules

Publications & Manuals

Go to Pubs

In The News

(October 24, 2024)

China-Based Chemical Manufacturing Companies and Employees Indicted for Alleged Fentanyl Manufacturing and Distribution

(October 24, 2024)

DEA Warns Healthcare Workers of Impersonation Scam Targeting Doctors and Pharmacists

(October 23, 2024)

Physician, Physician Assistant, and Practice Pay $300K to Resolve Controlled Substances Act Allegations

(October 23, 2024)

Physician, Physician Assistant, and Practice Pay $300K to Resolve Controlled Substances Act Allegations

(October 8, 2024)

Former Nurse Pleads Guilty in Connection with Diverting Fentanyl from ICU Patient

(October 3, 2024)

Multiple Pharmaceutical Distributor Executives, Sales Representatives and Brokers Charged in Connection with Unlawful Sales of over 70M Opioid Pills

(September 30, 2024)

U.S. Attorney Announces Charges Against 18 Defendants in Scheme to Manufacture and Distribute Millions of Deadly Counterfeit Pharmaceuticals Through Fake Online Pharmacies

What's New

(October 28, 2024)

Proposed Rule: Possible Control of Phenethyl Bromide as a List I Chemical (PDF)

(October 25, 2024)

Final Rule: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I (PDF)

(October 25, 2024)

30-Day Notice: Exempt Chemical Preparations Under the Controlled Substance Act (PDF)

(October 11, 2024)

Michael Berman, D.O.; Decision and Order (PDF)

(October 11, 2024)

William J. Mack, M.D.; Decision and Order (PDF)

(October 11, 2024)

Robert P. Hansen, M.D.; Decision and Order (PDF)